title: Attention deficit and hyperactivity disorder: a therapeutic option.
abstract: OBJECTIVE
  To evaluate the use of a therapeutic regimen to treat attention deficit hyperactivity disorder patients.
  
  
  METHODS
  A total of 140 patients initially underwent physical, neurological and laboratory evaluation. Thereafter, treatment was initiated with a compounding product consisting of a tricyclic antidepressant and an anxiolytic.
  
  
  RESULTS
  The response was positive in 71.43% of patients in controlling hyperactivity and improving dispersion and attention deficit.
  
  
  CONCLUSIONS
  The therapeutic regimen utilized proved to be an effective therapeutic alternative, especially for patients who do not adapt to psychostimulant drugs.
authors.affiliation: Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
authors.forename: Abram
authors.initials: A
authors.lastname: Topczewski
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D002707:Chlordiazepoxide; D007099:Imipramine